Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Liked2Thinkon Apr 05, 2021 6:06pm
132 Views
Post# 32939033

RE:RE:Never seen such a loss

RE:RE:Never seen such a lossI missed the $12M per year can someone else post that again for me.

3000 patients currently.  Pretty sure they already know they have cancer already and what kind of cancer since they are being treated by Care already.  So does this mean they need an Aristotle test every 3 months to determine how well things are going?  I thought the test detected cancer only and it didnt detect alittle bit of cancer or a lot of cancer.  Will it be done to see if the cancer is gone is that it?

Thats the problem what is the plan.  Apparently AVRT is active today yet we know nothing about it.

Most of us thought these were the steps
1. Anyone can get a Aristotle test from a supplier (large health care provider and small places like Ichor)
2. Postitive for cancer - directed to a local clinic for further testing and treatment Stage makes $1500
3. Negative for cancer - given a clean bill of health Stage makes $1500
4. Repeat every few years

Is it good they want to get in more of the further testing and treatment part?  Heck yeah it is but if we dont have someone big to partner with then this will be colon sentry all over again which went no where.
<< Previous
Bullboard Posts
Next >>